Newton Charles W. 4

4 · NOVAVAX INC · Filed Jun 23, 2026

AI-generated summary of this filing

Updated Jun 23, 2026

Novavax (NVAX) Director Charles W. Newton Receives Stock Awards

What Happened

Charles W. Newton, a director of Novavax, received two equity awards on 2026-06-18: an option-style grant covering 21,270 derivative shares (reported at $0.00) and 14,180 restricted stock units (RSUs) (reported at $0.00), for a total of 35,450 shares subject to award. These were reported on a Form 4 filed 2026-06-23. The transaction codes are "A" (award/grant); no shares were sold or purchased for cash.

Key Details

Transaction date: 2026-06-18; Form 4 filed: 2026-06-23 (appears to be one business day late vs. the 2-business-day rule).
Pricing: $0.00 per share reported — indicates stock awards/grants, not open-market purchases.
Shares after transaction: not specified in the provided filing excerpt.
Footnotes of note:
- F1: The 21,270-share option grant vests 100% on the first anniversary of the 6/18/2026 grant date, subject to continued Board service.
- F2: Each RSU equals a contingent right to receive one share of Novavax common stock.
- F3: The 14,180 RSUs vest 100% on the first anniversary of the 6/18/2026 grant date, subject to continued Board service.
Transaction type: derivative awards (options/RSUs) — not an immediate sale or cash exercise.

Context

These awards are compensatory grants that typically vest over time and are common for directors; they do not represent an immediate cash investment or sale. Options must be exercised and RSUs convert to shares only upon vesting and any applicable settlement. The late filing (filed 6/23 for 6/18 transaction) is procedural and may be subject to SEC reporting rules or company disclosure policies.

Form 4

Period: 2026-06-18

Director

Transactions

Award
Stock Option (Right to Buy)
[F1]
2026-06-18+21,270→ 21,270 total
Exercise: $9.13Exp: 2036-06-18→ Common Stock (21,270 underlying)
Award
Restricted Stock Units
[F2][F3]
2026-06-18+14,180→ 14,180 total
→ Common Stock (14,180 underlying)

Footnotes (3)

[F1]One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date.
[F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
[F3]One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date.

Signature

/s/ Mark J. Casey, Attorney-in-Fact|2026-06-23

1 file